Position in TLRY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,065
-$911 QoQ
Shares Held
460
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#142
of 234 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hurley Capital, LLC holds $618,119 across 8 Drug Manufacturers - Specialty & Generic names. TLRY ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
7,435 | $592,792 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
219 | $7,592 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
|
1,569 | $6,527 | |
| 4 | TRLV |
Trulieve Cannabis Corp.
|
526 | $5,170 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
100 | $3,388 | |
| 6 | TLRY |
Tilray Brands, Inc.
This page
|
460 | $2,065 | |
| 7 | CRON |
Cronos Group Inc.
|
125 | $347 | |
| 8 | VTRS |
Viatris Inc
|
15 | $238 |
All Filings in TLRY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,065 | 460 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,976 | 460 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,153 | 460 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,959 | 4,601 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $164 | 401 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $264 | 401 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $533 | 401 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||